Palevsky Paul M, Baldwin Ian, Davenport Andrew, Goldstein Stuart, Paganini Emil
VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15240, USA.
Curr Opin Crit Care. 2005 Dec;11(6):548-54. doi: 10.1097/01.ccx.0000179936.21895.a3.
Although renal replacement therapy is the mainstay of supportive care in patients with severe acute renal failure, its performance can have untoward effects that contribute to the prolongation of renal failure or impede the ultimate recovery of renal function. In this review, we categorize the major complications associated with renal replacement therapy and assess their impact on recovery of renal function.
The major mechanisms by which renal replacement therapy is postulated to delay renal recovery include treatment-associated hemodynamic instability, vascular catheter-related bacteremia and sepsis, and cytokine activation by bioincompatible membranes. Clinical data regarding the role of dialysis catheter infections in delay of renal recovery are lacking. The data regarding the role of membrane biocompatibility and the modality and dose of renal replacement therapy are limited and conflicting.
Clinical recommendations must be limited to the broad admonishment that complications during renal replacement therapy, including hemodynamic instability and catheter-related bacteremia, be minimized by using best clinical practices, while recognizing that the impact of specific practices on recovery of renal function have not been evaluated. The data do not support recommendations regarding utilization of specific membranes or the modality or dose of renal replacement therapy on the basis of their impact on recovery of renal function.
尽管肾脏替代治疗是重症急性肾衰竭患者支持治疗的主要手段,但其实施过程可能产生不良影响,导致肾衰竭持续时间延长或阻碍肾功能的最终恢复。在本综述中,我们对与肾脏替代治疗相关的主要并发症进行分类,并评估它们对肾功能恢复的影响。
推测肾脏替代治疗延迟肾功能恢复的主要机制包括治疗相关的血流动力学不稳定、血管导管相关菌血症和败血症,以及生物不相容膜激活细胞因子。关于透析导管感染在延迟肾功能恢复中作用的临床数据缺乏。关于膜生物相容性以及肾脏替代治疗方式和剂量作用的数据有限且相互矛盾。
临床建议必须局限于宽泛的告诫,即通过采用最佳临床实践将肾脏替代治疗期间的并发症(包括血流动力学不稳定和导管相关菌血症)降至最低,同时认识到特定实践对肾功能恢复的影响尚未得到评估。现有数据不支持基于对肾功能恢复的影响而对特定膜的使用或肾脏替代治疗的方式及剂量提出建议。